Immunovant, Inc. (IMVT)
NASDAQ·Healthcare·Biotechnology
$39.02
+0.41%
Mkt Cap $8.23B
Analyst Ratings
Buy
6
Hold
2
Sell
0
Price Target (10 analysts)
$40.00
Range $40.00 – $40.00
Implied Upside
+2.5%
Consensus $40.00 vs current $39.02
NASDAQ·Healthcare·Biotechnology
$39.02
+0.41%
Mkt Cap $8.23B
Buy
6
Hold
2
Sell
0
Price Target (10 analysts)
$40.00
Range $40.00 – $40.00
+2.5%
Consensus $40.00 vs current $39.02